Updates

Get Alerts
With a free MyAccess profile, you can sign up to receive an email alert when new content is published on this site.
October 15, 2021 | PPP Updates
Aducanumab-avwa (Aduhelm): A Novel Therapy for Mild Alzheimer Disease
Casey M. Tiefenthaler, PharmD, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
September 9, 2021 | PPP Updates
Amivantamab Approved for Treatment of EGFR exon 20 insertion-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer
Jill M. Kolesar, PharmD, MS
September 3, 2021 | PPP Updates
Dual Antiplatelet Therapy Duration after Percutaneous Coronary Interventions
Kelly C. Rogers, Pharm.D., BCCP, FCCP, FACC
August 5, 2021 | PPP Updates
Lifestyle Changes that Reduce Symptoms of Gastroesophageal Reflux Disease (GERD)
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA
August 5, 2021 | PPP Updates
Cabotegravir/Rilpivirine Approved for Treatment of Stable HIV Patients as Extended-Release Antiretroviral Regimen
Y. Vivian Tsai, PharmD, Caroline Derrick, PharmD, BCPS
July 23, 2021 | PPP Updates
Viloxazine (Qelbree): A New Non-Stimulant Medication for Pediatric ADHD
Kevin Kavanagh, PharmD
June 15, 2021 | PPP Updates
Sotorasib Approved for Treatment KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer
Jill M. Kolesar, PharmD, MS
June 15, 2021 | PPP Updates
New Guidelines for Selection of Glucose-lowering Medication in Type 2 Diabetes
Julie M. Sease, PharmD, FCCP, BCPS, CDCES, BCACP
May 27, 2021 | PPP Updates
FDA Issues Another Safety Alert for the Janus-Kinase Inhibitor Tofacitinib (Xeljanz)
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA
May 27, 2021 | PPP Updates
Vyepti (eptinezumab-jjmr): A CGRP Antagonist for Migraine Prevention
Kevin T. Nguyen, PharmD, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
April 30, 2021 | PPP Updates
Margetuximab-cmkb (Margenza) Approved for Treatment of Metastatic HER2-Positive Breast Cancer
Keng Hee Peh, PharmD, MS, Jill M. Kolesar, PharmD, MS
April 30, 2021 | PPP Updates
FDA Approves Liraglutide (Saxenda) for Chronic Weight Management in Children Ages 12 and Older
Nicole Cheung, PharmD, BCPS, Valerie Marcellus, PharmD, BCACP, Ukamaka Diké Smith, PharmD, MBA
April 8, 2021 | PPP Updates
COVID-19 Vaccines Update
Diane M. Cappelletty, PharmD, Jeremiah Hendra, PharmD
April 8, 2021 | PPP Updates
Guidelines for Obstetrician–Gynecologists on Chronic Hypertension in Pregnancy
Jonathan T. Huff, PharmD, Augustus Hough, PharmD, BCPS, BCCP
February 24, 2021 | PPP Updates
Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List
Emily Eddy, PharmD, BCACP, BC-ADM
February 24, 2021 | PPP Updates
Clascoterone: The First Topical Androgen Receptor Inhibitor Approved for Acne Treatment
Jenna M. Mills, PharmD
February 24, 2021 | PPP Updates
Updated Gonorrhea Treatment Recommendations
P. Brandon Bookstaver, PharmD, FCCP, FIDSA
February 15, 2021 | PPP Updates
Clinical Guideline on Nonpharmacologic and Pharmacologic Management of Acute Pain from Non–Low Back Musculoskeletal Injuries in Adults
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA, Professor Emeritus
January 29, 2021 | PPP Updates
Lumateperone (Caplyta): An Atypical Antipsychotic for Treatment of Schizophrenia
Elika Hefazi, PharmD, BCPP, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
November 19, 2020 | PPP Updates
Challenges in Solid Organ Transplantation Due to the Generic Tacrolimus Shortage
Benjamin T. Duhart, Jr., MS, PharmD, Associate Professor
October 28, 2020 | PPP Updates
Sacituzumab govitecan-hziy (Trodelvy) Approved for Treatment of Metastatic Triple-Negative Breast Cancer
Rachael Stone, PharmD Candidate, Jill M. Kolesar, PharmD, MS
October 28, 2020 | PPP Updates
Results of a Comparative Trial of Upadacitinib vs Abatacept for Rheumatoid Arthritis
Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA
October 28, 2020 | PPP Updates
Ozanimod (Zeposia) Approved for Multiple Sclerosis Treatment
Anamika Nijum, PharmD, PGY1, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
September 29, 2020 | PPP Updates
Ozanimod (Zeposia) Approved for Multiple Sclerosis Treatment
Anamika Nijum, PharmD, Kelly C. Lee, PharmD, MAS, FCCP, BCPP
September 8, 2020 | PPP Updates
Brexucabtagene Autoleucel (Tecartus) Approved for Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL) in Adults
Jill M. Kolesar, PharmD, MS